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The molecular mobility of glass and supercooled liquid states of nilutamide has been studied with broadband
dielectric spectroscopy for a wide range of temperature and frequency. Besides primary α-relaxation an ex-
cess wing like secondary relaxation is observed. The temperature dependence of structural α-relaxation show
non-Arrhenius behaviour, and follows Vogel-Fulcher-Tammann (VFT) empirical formula. The glass transi-
tion temperature, Tg=302K and fragility index, m=76 are obtained from the VFT parameters. The struc-
tural α-relaxation process is non-Debye with Kohlraush-Williams-Watts stretched exponential βKWW=0.76.
Secondary relaxation time of nilutamide coincides with the primitive relaxation time calculated from the
coupling model. Hence the secondary relaxation process of nilutamide is treated as the Johari-Goldstein
(JG) β-process, which is the precursor of the structural α-process. Recent report on nilutamide indicates the
increase of nucleation even below Tg, however we attributed to the JG β-relaxation. During the dielectric
measurements amorphous nilutamide recrystallizes. The crystallization of amorphous nilutamide has been
studied by the isotherm dielectric measurements at T=326K over a period of time. The crystallization follows
Avrami equation and the parameters are obtained.
I. INTRODUCTION
Pharmaceuticals in amorphous form are more relevant
due to their improved solubility and bioavailability as
compared with the crystalline form, which are poorly
water soluble. About 40% of pharmaceuticals are poorly
water soluble and results in inadequate bioavailability1.
Amorphous materials are metastable with tendency to
recrystallize. It was noted that even the sample kept
many degrees below the glass transition temperature,
may undergo recrystallization during the storage time2,3.
A key factor which affect the stability of amorphous
phase and tendency towards crystallization is molecular
mobility4–6.
Broadband dielectric spectroscopy is widely used tech-
nique to study dielectric relaxation and molecular dy-
namics of glasses, supercooled liquids, polymers and even
disordered semiconductors7,8. The dielectric relaxation
studies of pharmaceutical samples with broad band di-
electric spectroscopy is very useful since the knowledge of
molecular dynamics may leads to improve bioavailability
and stability9–11. The molecular motions responsible for
the crystallization from the glass are an important topic.
Hence, the study of molecular dynamics through dielec-
tric relaxation of liquid and glassy phase of pharmaceu-
ticals are very common10–12. The existed crystallization
model proposes that the molecular process responsible for
crystal growth in glassy state is from the local molecular
motions13,14. Crystal nucleation requires motion of the
entire molecule and Johari Goldstein (JG) β-relaxation
is credited to the initial process of crystallization15.
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Nilutamide is one of the relevant active pharmaceuti-
cal drugs used for the treatment of prostate cancer. Ni-
lutamide is one of the compounds, which is poorly wa-
ter soluble in crystalline form. Nilutamide is classified
as slowly crystallizing compound16,17. Nucleation and
crystal growth of amorphous nilutamide has been inves-
tigated using DSC, FTIR, Raman spectroscopy, NMR
by Transi and Taylor18 and reported unusual case of in-
creased nucleation rate of metastable poly morph even
at temperature below Tg. However, no investigation is
reported in literature for the molecular motion of liquid
and glassy states of nilutamide. In the present work, di-
electric relaxation of supercooled liquid and glassy states
of nilutamide is studied with broadband dielectric spec-
troscopy. The crystallization of amorphous nilutamide
studied with the isotherm dielectric measurements at
temperature 326 K. This is the first attempt to de-
scribe the molecular mechanism and crystallization of
amorphous nilutamide using broadband dielectric spec-
troscopy.
II. MATERIALS AND METHODS
A. Materials
Nilutamide (5,5-dimethyl-3-[4-nitro-3-
(trifluoromethyl)phenyl]imidazolidine-2,4-dione) with
chemical formula C12H10F3N3O4, in crystalline powder
form was purchased from Sigma Aldrich and used for
the experimental studies. The molecular structure of
nilutamide is shown in Fig. 1.
2FIG. 1. Molecular structure of nilutamide
B. Methods
1. Raman spectroscopic measurements
Raman spectroscopic measurement of crystalline and
amorphous nilutamide has been obtained with 514 nm
radiation. Raman shift of the range of 100 to 1800 cm−1
has been obtained. Raman spectrum of crystalline (pow-
der) sample is obtained at room temperature. Crystalline
powder of the sample is melted by heating above melt-
ing temperature (Tm=426 K), and then it is quenched to
153 K with cooling rate of 15 K/min. Hence formed nilu-
tamide glass is subjected to Raman measurements. Ra-
man measurements of glassy and supercooled nilutamide
have been carried out for various temperatures from 153
K to 348 K.
2. Broadband dielectric spectroscopy measurements
The dielectric measurement was performed using stain-
less steel sample cell with 0.2 mm thick and 30mm diam-
eter. Teflon was used as the spacer for the electrodes.
Complex dielectric data was taken for a frequency range
of 10−2Hz to 107Hz for various temperature with alpha
analyser of Novocontrol broad band dielectric spectrom-
eter which has a temperature controller of nitrogen gas
cryostat with a temperature stability of 0.1 K. The sam-
ple was carefully filled in the sample cells and heated to
slightly above the melting temperature 383 K for 20 min-
utes and made into melt. It is pressed well and avoids
formation of bubbles. It is subjected to fast cooling with
a cooling rate of 15 K/min to a temperature of 123 K.
Complex dielectric measurements of glassy and super-
cooled sample have been carried out for a temperature
range 193 K to 338 K in proper steps.
III. RESULTS AND DISCUSSION
A. Raman spectra
The crystalline powder form of nilutamide shows all
characteristic peaks of stable nilutamide as shown in Fig.
2(A). Nilutamide is observed in stable and metastable
forms. Melt quenched nilutamide show broader peaks
and do not show significant variation for the tempera-
ture range of 153 K to 308 K. Raman spectra of glassy
nilutamide for typical temperatures are shown in Fig.
2(B). Raman spectra at temperature 318 K and above
show show well defined peaks as shown in Fig. 2(A).
The glassy nilutamide recrystallized in the metastable
form. For the stable form the most intense peak oc-
curred at 1372 cm−1 while for metastable form it oc-
curred at 1357 cm−1 very much similar as observed by
Transi and Taylor18. Initial powder form show stable ni-
lutamide while glassy and recrystallized materials show
metastable form. Two peaks at 1602 cm−1 and 1622
cm−1 in the stable form are shifted to lower wavenum-
bers in the metastable forms (1598 cm−1 and 1616 cm−1
respectively). The metastable also show a notable de-
crease in the intensity of carbonyl stretching bands be-
tween 1700 - 1800 cm−1 with 1700 cm−1 peak being much
weaker as in the earlier studies18. Raman spectroscopy of
glassy and crystalline states of nilutamide studies show
the amorphous nilutamide is more similar to the meta-
stable states of nilutamide and it recrystallizes to the
meta-stable states above T=318 K.
(A)
(B)
FIG. 2. (A). Raman spectra of nilutamide in crystalline (pow-
der) and recrystallized form (B). Raman spectra of glassy
form of nilutamide at two typical temperatures.
B. Dielectric relaxation studies
The dielectric loss data of glassy and supercooled ni-
lutamide, below and above Tg are shown in Fig. 3(A)
and (B) respectively. The real part of complex dielec-
3(A) (B)
FIG. 3. (A). The dielectric loss data below Tg do not show well defined secondary processes. (B). The dielectric loss data
above Tg structural α relaxation process, excess wing like secondary process and dc conductivity due to translational motion
of ions. The dielectric loss data are fitted with σdc and HN function for the α relaxation process.
tric data is shown in Fig. 4. The dielectric loss data
FIG. 4. Real part of dielectric permittivity at temperature
above Tg . Nilutamide show a dramatic change in dielectric
strength above the temperature 326 K, as an indication of
crystallization of the sample.
below Tg does not show well resolved secondary relax-
ation process. The dielectric loss data above Tg show
the structural α-relaxation process and excess wing like
secondary process. Dielectric loss at high temperatures
also constitutes the dc conductivity contribution due to
the translational motion of free ions. Generally the com-
plex dielectric permittivity of can be fitted with,
ε∗(ω)= −i
σdc
ε0ω
+
∆εα
(1 + (iωτHN )αHN )βHN
+
∆εβ
(1 + (iωτCC)(1−αCC))
+ ε∞ (1)
where σdc is the dc conductivity, which contributes
σdc/(ε0ω) to the dielectric loss spectra. ε∞ is the high
frequency limit of dielectric constant. Primary α-process
originates due the structural relaxation with coopera-
tive motions of molecules are modelled with the asym-
metric function Harviliak-Negami19 (HN), with dielec-
tric strength ∆εα, relaxation time τHN and shape pa-
rameters αHN and βHN . The secondary process are
generally modelled with symmetric function Cole-Cole,
with dielectric strength ∆εβ , relaxation time τCC and
shape parameter αcc. The dielectric relaxation time of
α process τα is obtained as τmax, calculated from fit pa-
rameters of HN function20. Temperature dependence of
relaxation time and viscosity of the supercooled liquids
generally show non-Arrhenius behaviour. The structural
FIG. 5. The structural relaxation, α-process of nilutamide
shows non-Arrhenius behaviour and follows Vogel-Fulcher-
Tamman (VFT) equation.
relaxation, α-process is thermally activated as shown in
Fig. 5, which follows empirical Vogel-Fulcher-Tammann
4(VFT) equation21–23.
τα = τ∞exp[DT0/(T − T0)] (2)
where D is the strength parameter, T is absolute tem-
perature, τ0 is the high temperature limit of τα and T0 is
the VFT temperature at which all important molecular
motion would cease and relaxation time becomes infinity.
The glass transition temperature is a kinetic transition
that occurs when the system falls out of equilibrium due
to the increasingly restricted molecular mobility and in-
creasing viscosity, resulting in a glassy state24,25. The
temperature at which relaxation time τα=100s are gen-
erally considered as glass transition temperature12. Tg
of nilutamide is obtained as 302±11 K from the VFT
fit parameters and it is close agreement with the Tg ob-
tained from DSC measurement by Transi and Taylor18,
which is 305 K. Materials showing Arrhenius behaviour
are termed as “strong” and which exhibits non-Arrhenius
dependency are referred “fragile”. Fragility index is gen-
erally obtained from the Angell plot, which quantifies
the amount of deviation of relaxation time from Arrhe-
nius behaviour26. The fragility index m, can be obtained
from the VFT parameters as27
m =
dlog10τα
d(Tg/T )
∣∣∣∣
T=Tg
= D
T0
Tg
(
1−
T0
Tg
)
−2
log10e (3)
The typical value of fragility is between 16 and 200.
It is considered that the fragility index plays an im-
portant role to establish an appropriate storage con-
dition for the particular drug since it correlate with
the glass-forming ability and physical stability of amor-
phous systems. Fragility index describe the rapidity
with which a liquid structure, which was arrested at
the glass transition during cooling, becomes disrupted on
heating12. The fragility index of nilutamide, m=76±17
is obtained from Eq. 3 and VFT parameters. The er-
ror in fragility is obtained from the error in VFT pa-
rameters. Nilutamide can be classified as the interme-
diate glass-former drug. The ratio Tm/Tg=1.41, and
the difference, Tg − T0=64.7, are also indications of the
system is fragile. The fragility of nilutamide is com-
parable with other glass forming pharmaceuticals like,
glibenclamide28 (m=78), indapamide29 (m=76). It is
worth noting that many other molecular glass formers
like sqalane30 (m=75), phenolphthalein dimethylether31
(m=75), isoeugenol32 (m=73) has the similar fragility.
Debye dielectric relaxation function33 is given by
φ(t) = exp(−t/τD) where τD is the Debye relaxation
time and it produces a polarization current density jp ∝
−dφp(t)/dt. Corresponding to this relaxation function,
frequency dependent complex permittivity is obtained as
ε∗(ω) = εp/(1 + iωτD). Molecular relaxation process
in almost all glass-forming materials are non-exponential
and it is modelled with the stretched exponential function
known as Kohlarush-Williams-Watts (KWW) function15.
φ(t) = exp
[
−
(
t
τKWW
)βKWW ]
(4)
The KWW lacks a analytical function in frequency
domain for all values of exponent βKWW except for
βKWW=0.5. Taking one side Fourier transform of the
KWW is common for analysing the dielectric data.
The non-exponential behaviour of the dielectric relax-
ation is attributed to the distribution of molecular re-
laxation times. The scaled dielectric loss of near glass
transition temperature show KWW exponent has value
βKWW = 0.76 as shown in Fig. 6. The value
FIG. 6. The scaled dielectric loss data of nilutamide, near
glass temperatures with KWW fit (red curve). The dielec-
tric loss data are fitted with Harviliak-Negami function for
α-process (blue curve) and Cole-Cole function for secondary,
β-process (green curve). The primitive relaxation time τ0
obtained from the Ngai’s coupling model corresponds a fre-
quency f0 and the secondary process is almost near to the
primitive relaxation indicating the secondary relaxation pro-
cess is a Johari-Goldstein process.
of βKWW is comparable with other pharmaceutical
materials glibenclamide28 (βKWW=0.74), indapamide
29
(βKWW=0.72), acetaminophen
34 (βKWW=0.79). Sham-
blin et al., suggested that the distribution of structural
relaxation time may raise the crystal nucleation rate, and
consequently the shelf life of the pharmaceutical35. It has
been reported that the both physical and chemical stabil-
ity decreases with the decrease of value of βKWW . The
faster modes of molecular motions within the distribu-
tion of relaxation time can be responsible for the nucle-
ation in the glassy state, therefore the glass formers with
smaller βKWW would be more susceptible to nucleate
36.
But it should be noted down many of the pharmaceutical
materials do not show the expected correlation between
βKWW and tendency of crystallization
12. The stretch-
ing parameter βKWW has been often considered as a
measure of degree of cooperativity and length scale or
dynamic heterogeneity of molecular mobility reflected in
the structural relaxation12. Thus βKWW is also refer-
eed as alternative parameter to the fragility index m in
search of correlation with tendency of crystallization.
Understanding the physical origin of secondary relax-
ation processes in glass forming materials is really chal-
5lenging. It is widely accepted that the secondary pro-
cess may originate either from the motion of the entire
molecule or intermolecular process. The secondary pro-
cess of intramolecular origin may be called γ-process.
It was observed that there is a possible secondary re-
laxation process called Johari-Goldstein (JG) process,
which are precursors of the primary structural relaxation
process37,38. The JG relaxation is generally referred as
the β-process and it is considered to be universal pro-
cess in glass forming materials. Ngai has used a cou-
pling model (CM) to identify the nature of the secondary
process39,40. The CM predicts a correlation of relaxation
time of JG process, τβ with the relaxation time of α-
process τα. The primitive relaxation time can be ob-
tained from the empirical relation,
τ0 = (tc)
n(τα)
(1−n) (5)
where, tc is the time characterizing the crossover from
independent to cooperative fluctuation. For small glass
formers its value is nearly 2×10−12 s. The coupling pa-
rameter, n=1-βKWW can be obtained from the struc-
tural α relaxation process. According to CM the scaled
dielectric data should have primitive relaxation time
τ0 = 3.8×10
−4 s, which corresponds to the frequency of
413 Hz approximately. Generally secondary relaxation
follows Arrhenius temperature dependence. To resolve
secondary relaxation from the nearby α process is rather
difficult, except some temperatures nearby Tg. Hence
attempts to resolve α-process and β-process, have made
only for the scaled dielectric loss data at temperatures
near Tg as shown in Fig. 6. The master curve of dielec-
tric loss is fitted using the Eq.1, without dc conductiv-
ity contribution. The secondary relaxation follows Cole-
Cole dielectric relaxation function with relaxation time
τCC=3.2×10
−4 s, which is close agreement with the prim-
itive relaxation time τ0 predicted by the coupling model.
Hence the secondary relaxation observed in nilutamide
can considered as the JG β-process (τ0 ≈ τβ), originates
due to the motion of the entire molecule. Even though
there is a possibility of hydrogen bonding in nilutamide
the secondary relaxation process of the glass former is JG
β-relaxation or closely resembling JG relaxation since it
follows coupling model criteria38.
It is observed that the fragility factor m and stretched
exponential factor βKWW are similar for glibenclamide
28,
indapamide29 and present sample of interest nilutamide
but with different VFT parameters and Tg. Nilutamide
did not show explicit γ-process as in glibenclamide and
indapamide. No γ-process is observed and it may be
due to the absence of strong intramolecular motions of
subgroups of nilutamide.
Paluch et al., found that the width of α-loss peak
near Tg is strongly anticorrelates with the polarity of the
molecule especially of van der Waals glass formers. Hence
larger the dielectric loss strength ∆εα of glass former,
lesser the value of βKWW of the α-relaxation process
41.
This has been described as the contribution of dipole-
dipole interaction potential, Vdd ∝r
−6 (r is the distance
between the molecules), to the intermolecular potential
which makes the resultant potential more harmonic. Ni-
lutamide has ∆εα=10.8 and βKWW=0.76, near Tg. Even
though there is a possibility of hydrogen in nilutamide,
it shows similar behaviour as isooctylcyanobiphenyl41.
Crystallization from organic undercooled melts is an
important topic of investigation. Combined process of
nucleation and crystal growth results the crystallization
from glasses/supercooled liquids. As the temperature in-
creases, the rate of crystal growth increases due to the
increase of molecular mobility. Nucleation is a prereq-
uisite to the crystal growth. Hence storing the sam-
ple at temperature where the nucleation rate is low
will help to prevent the crystallization from glasses.
Many materials show recrystallization during the stor-
age time, even though they kept several degrees below
Tg
2,3. The molecular motions responsible for the sec-
ondary relaxation may be the key factor for such ten-
dency of crystallization4–6.
Nilutamide DSC measurements do not show recrys-
tallization due to the rate of nucleation and/or crystal
growth is slow relative to the time scale of the DSC
measurements18. It is observed that the melt had to be
cooled to at least 243 K for crystallization to observed
upon heating18. Raman and dielectric measurements has
been carried out to the quenched melt below 153 K. Dur-
ing dielectric spectroscopic measurements the amorphous
nilutamide show recrystallization during heating above
the temperature of 326 K. The dielectric strength of α-
process decreases with increase of temperature above 326
K as shown in Fig. 4. This indicates that the molecule
have sufficient kinetic energy at this temperature to start
the crystal growth. The dramatic change in the dielectric
strength of α-process is a signature of the crystallization
phenomena. During crystallization the relaxation time
τα is almost same for considerable period of time. The
crystalline region of the material do not contribute to the
dielectric response of α-process. The density of mobile
dipoles decreases and hence the intensity of the structural
relaxation. The dielectric measurements at constant tem-
perature 326 K at ambient pressure show a decrease in
dielectric strength with time as an indication of increase
of crystal growth and it is shown in Fig. 7.
The amount of crystallization can be estimated from
the dielectric spectra using the normalized change in the
dielectric dispersion ε′N (t)
α(t) = ε′N (t) = 1−
∆ε(t)
∆ε(0)
= 1−
ε′(t)− ε′(∞)
ε′(0)− ε′(∞)
= 1− exp[−(kt)n] (6)
where the conversion degree α is a measure of how rapidly
active dipoles decreases during the crystallization pro-
cess and it is connected to Avrami function12,42,43. The
parameter k is the overall crystallization rate constant
which includes both nucleation and growth. Avrami ex-
ponent n, correlates with the nature of crystal growth.
The crystallinity fraction obtained from Eq. 6 for the di-
electric data at 10 Hz of crystallizing nilutamide is shown
6(A)
(B)
FIG. 7. (A). Imaginary and (B). real part of permittivity at
temperature 326 K for various time. The dielectric data at
initial, 2.78 min. and time interval of 14.12 min. are shown
in the figure.
in Fig. 8. The Avrami exponent n has a value 1.76±0.01
at temperature 326K at ambient pressure. The crystal-
lization rate constant k is obtained as 2.81±0.01×10−4
s−1. Nilutamide has a fairly rapid growth rate. The good
glass forming ability and lack of crystallization during
cooling from melt may be from its low nucleation ten-
dency. The Raman measurements show that the recrys-
tallized sample is in the metastable form. The physical
parameters of nilutamide obtained from the dielectric re-
laxation studies are listed in Table I.
Nilutamide has three hydrogen bond acceptors and one
donor group. Transi and Taylor considered the hydro-
gen bond between the amide group and carbonyl group
which results the formation of chain of molecules18. More
extensive hydrogen bonding is found in the metastable
form as compared to the stable form. One of the possi-
ble origins of the metastable form is the conformational
polymorphs due to different dihedral angle formed by
the plane of two rings of nilutamide. Calculations of
Transi and Taylor, show that minimum energy occurs
when the rings are at angle 30◦ and conformational anal-
ysis show the stable polymorph nilutamide molecule is
FIG. 8. Crystallization fraction as obtained from Eq.6 for
the dielectric data at 10 Hz, of the crystallizing nilutamide at
temperature of 326 K.
not planar but the phenyl ring rotated relative to the
imidazole ring by about 54.4◦ leading to a higher en-
ergy conformer that may be stabilized by interaction in
crystal18. Recent studies show ibuprofen nucleate into
metastable form (conformational poly-morph) above and
below the glass transition temperature44,45. There are
possibilities of maximum nucleation rate at temperature
much below Tg and the nucleation is controlled by JG
β-process, rather than viscosity46.
IV. CONCLUSION
Important pharmaceutical drug, nilutamide is melt-
quenched and studied the molecular dynamics of glassy
and supercooled states using broadband dielectric spec-
troscopy. The dielectric loss data show structural α-
relaxation process and excess wing like secondary re-
laxation process. The α-process is a thermally acti-
vated non-Arrhenius process which follows VFT equa-
tion. Glass transition temperature and Tg=302 K is ob-
tained from the dielectric spectra by the assumption of
τα=100 s at Tg. The VFT parameter of α-process indi-
cates nilutamide is a moderate fragile glass-former with
fragility index m=76. The α-process is a non-Debye with
KWW stretched exponential parameter β=0.76, near
glass transition temperatures. Based on Ngai’s coupling
model the secondary process is a Johari-Goldstein pro-
cess which may be the precursor of the structural α-
process. Nilutamide do not show secondary γ-process
and it may be due to the absence of strong intramolec-
ular motions of subgroups. The dielectric data of nilu-
tamide show, the strong anticorrelation of width of α
relaxation process with the dielectric loss strength pre-
dicted by Paluch and coworkers. Nilutmaide crystallizes
7TABLE I. Physical parameter obtained for nilutamide using dielectric relaxation studies.
T0 [K] D log(τ0) Tg [K] Fragility ∆εα(Tg) βKWW
237.3±2.8 11.1±0.9 -15.7±0.5 302±11 76±17 10.8±0.2 0.76±0.02
during the dielectric measurements and the strength of
α-process decreases during crystallization as the density
of mobile dipole decreases. Isotherm dielectric measure-
ments at 326 K have been carried out for various times.
Avrami parameters n and k is found to be 1.76 and
k=2.81×10−4 s−1 respectively at temperature T=326
K. Non-crystallization during cooling from the melt and
good glass forming ability of the nilutamide may be at-
tributed to the low nucleation tendency. The former re-
port on the increased rate of nucleation below Tg may
be attributed to the observed JG β relaxation of glassy
nilutamide.
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